Catapres and Dolutegravir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Catapres (clonidine hydrochloride) and Dolutegravir (dolutegravir). Common drug interactions include asthma among females.
The phase IV clinical study analyzes what interactions people have when they take Catapres and Dolutegravir. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Catapres?
Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.
What is Dolutegravir?
Dolutegravir has active ingredients of dolutegravir. eHealthMe is studying from 7,071 Dolutegravir users. Check the latest studies of Dolutegravir.
15 people who take Catapres and Dolutegravir together, and have interactions are studied.
What are the common drug interactions of Catapres and Dolutegravir, by gender? *:
female:
- Asthma
- Back pain
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Food allergy
- Headache (pain in head)
- Hepatic enzyme increased
- Hyperhidrosis (abnormally increased sweating)
- Immunodeficiency
- Infusion related reaction
- Joint swelling
male:
n/a
What are the common drug interactions of Catapres and Dolutegravir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Asthma
- Back pain
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Food allergy
- Headache (pain in head)
- Hepatic enzyme increased
- Hyperhidrosis (abnormally increased sweating)
- Immunodeficiency
- Infusion related reaction
- Joint swelling
60+:
n/a
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 100.00%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 15 people, 100.00%
- Herpes Zoster: 12 people, 80.00%
- Pain: 2 people, 13.33%
- Depression: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Catapres and Dolutegravir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Catapres (6,680 reports)
- Dolutegravir (7,071 reports)
Browse all drug interactions of Catapres and Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Catapres:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Catapres and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dolutegravir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on clonidine hydrochloride and dolutegravir (the active ingredients of Catapres and Dolutegravir, respectively), and Catapres and Dolutegravir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mepergan cause Prostate Cancer Metastatic? - 13 seconds ago
- Could Vx-950 cause High Blood Pressure? - 15 seconds ago
- Haemolytic Anaemia and Agranulocytosis - 34 seconds ago
- Could Naglazyme cause Insomnia? - 41 seconds ago
- Could Monopril cause Vasodilatation? - 49 seconds ago
- Drug interactions of Prolia and Amlodipine Besylate - 56 seconds ago
- Could Claritin cause Bone Density Decreased? - a minute ago
- Adderall 15 vs. Phentermine, side effect and effectiveness comparison - a minute ago
- Spiriva vs. Brovana, side effect and effectiveness comparison - a minute ago
- Phentermine vs. Belviq, side effect and effectiveness comparison - a minute ago